Author
Number of items: 9.
Article
Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting : A meta-analysis of patients with left main coronary artery disease. (2017)
Nikolaos Spinthakis,
Mohamed Farag,
Diana A Gorog,
Abhiram Prasad,
Hamid Mahmood,
Ying Gue,
David Wellsted,
Ashraf Nabhan
and
Manivannan Srinivasan
![]()
Catheter ablation for AF improves global thrombotic profile and enhances fibrinolysis. (2017)
Maria Niespialowska-Steuden,
Vias Markides,
Mohamed Farag,
David Jones,
Wajid Hussain,
Tom Wong
and
Diana A Gorog
![]()
Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention. (2017)
Christos Christopoulos,
Mohamed Farag,
Keith Sullivan,
David Wellsted
and
Diana A Gorog
![]()
PAR-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease. (2014)
G. Rosser,
P. Tricoci,
D. Morrow,
C. Christopoulos,
M. Niespialowska-Steuden,
Robert Kozarski,
R. Wilcox
and
Diana Gorog
Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential. (2014)
Diana Gorog,
J. Yamamoto,
N. Inoue,
K. Otsui
and
H. Ishii
Novel oral anticoagulants in acute coronary syndrome. (2013)
C. Costopoulos,
M. Niespialowska-Steuden,
N. Kukreja
and
Diana Gorog
Novel antithrombotic agents for atrial fibrillation. (2012)
M.M. Niespialowska-Steuden,
Diana Gorog
and
V. Markides
Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction. (2010)
S. Saraf,
C. Christopoulos,
I.B. Salha,
D. Stott
and
Diana Gorog